DLB vs PATH
Dolby Laboratories (DLB) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Dolby Laboratories (DLB) is a specialty business services company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported DLB revenue for 2025-09-26 was $1.35B. Net income was $256.5M. Revenue was up 5.9% from 2024-09-27 to 2025-09-26. DLB currently screens at market cap $7.19B and trailing P/E 28.3.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
DLB currently screens at market cap $7.19B and trailing P/E 28.3. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the DLB and PATH stock pages for the full models.
Not investment advice.